Cochlear Limited (ASX:COH – Get Free Report) insider Karen Penrose purchased 100 shares of the company’s stock in a transaction dated Wednesday, February 18th. The stock was purchased at an average cost of A$201.22 per share, for a total transaction of A$20,122.00.
Cochlear Stock Performance
The company has a current ratio of 2.30, a quick ratio of 1.93 and a debt-to-equity ratio of 13.24. The firm has a market capitalization of $19.88 billion, a PE ratio of 55.90, a price-to-earnings-growth ratio of 3.87 and a beta of 0.47.
Cochlear Dividend Announcement
The company also recently declared a Interim dividend, which will be paid on Sunday, April 12th. Shareholders of record on Sunday, April 12th will be issued a dividend of $2.15 per share. This represents a yield of 107.0%. The ex-dividend date is Wednesday, March 18th. Cochlear’s dividend payout ratio is 77.35%.
Cochlear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than Cochlear
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- From Quiet Compounder to 2026 Breakout? BSEM
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
